A Neuroendocrine Role for Chemerin in Hypothalamic Remodelling and Photoperiodic Control of Energy Balance
Authors
Affiliations
Long-term and reversible changes in body weight are typical of seasonal animals. Thyroid hormone (TH) and retinoic acid (RA) within the tanycytes and ependymal cells of the hypothalamus have been implicated in the photoperiodic response. We investigated signalling downstream of RA and how this links to the control of body weight and food intake in photoperiodic F344 rats. Chemerin, an inflammatory chemokine, with a known role in energy metabolism, was identified as a target of RA. Gene expression of chemerin (Rarres2) and its receptors were localised within the tanycytes and ependymal cells, with higher expression under long (LD) versus short (SD) photoperiod, pointing to a physiological role. The SD to LD transition (increased food intake) was mimicked by 2 weeks of ICV infusion of chemerin into rats. Chemerin also increased expression of the cytoskeletal protein vimentin, implicating hypothalamic remodelling in this response. By contrast, acute ICV bolus injection of chemerin on a 12 h:12 h photoperiod inhibited food intake and decreased body weight with associated changes in hypothalamic neuropeptides involved in growth and feeding after 24 hr. We describe the hypothalamic ventricular zone as a key site of neuroendocrine regulation, where the inflammatory signal, chemerin, links TH and RA signaling to hypothalamic remodeling.
Palomba S, Seminara G, Costanzi F, Caserta D, Aversa A Biomedicines. 2025; 12(12.
PMID: 39767764 PMC: 11672894. DOI: 10.3390/biomedicines12122859.
A Cross-Sectional Study: Systematic Quantification of Chemerin in Human Cerebrospinal Fluid.
Hopfinger A, Behrendt M, Schmid A, Karrasch T, Schaffler A, Berghoff M Biomedicines. 2024; 12(11).
PMID: 39595074 PMC: 11592017. DOI: 10.3390/biomedicines12112508.
Progress in the contrary effects of glucagon-like peptide-1 and chemerin on obesity development.
Zhang Q, Ye J, Wang X Exp Biol Med (Maywood). 2023; 248(22):2020-2029.
PMID: 38058030 PMC: 10800121. DOI: 10.1177/15353702231214270.
Adipokines as Clinically Relevant Therapeutic Targets in Obesity.
Wurfel M, Bluher M, Stumvoll M, Ebert T, Kovacs P, Tonjes A Biomedicines. 2023; 11(5).
PMID: 37239098 PMC: 10216759. DOI: 10.3390/biomedicines11051427.
Kannangara H, Cullen L, Miyashita S, Korkmaz F, Macdonald A, Gumerova A Ann N Y Acad Sci. 2023; 1525(1):61-69.
PMID: 37199228 PMC: 10524199. DOI: 10.1111/nyas.15009.